Determinants of Myelosuppression in the Treatment of Non‐small Cell Lung Cancer with Cisplatin‐containing Chemotherapy

Data on 16 potential risk factors for myelosuppression were assessed in 134 patients who received either vindesine and cisplatin (VP) or mitomycin C, vindesine and cisplatin (MVP) for inoperable stage III or IV non‐small cell lung cancer in a randomized trial. Determinant factors for myelosuppressio...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Jpn J Cancer Res
Main Authors: Matsui, Kaoru, Masuda, Noriyuki, Uchida, Yasuo, Fukuoka, Masahiro, Negoro, Shunichi, Yana, Takashi, Kusunoki, Yoko, Kudoh, Shinzoh, Kawase, Ichiro, Kawahara, Masaaki, Ogawara, Mitsumasa, Kodama, Nagahisa, Kubota, Kaoru, Furuse, Kiyoyuki
Formato: Artigo
Idioma:Inglês
Publicado em: Blackwell Publishing Ltd 1996
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5921149/
https://ncbi.nlm.nih.gov/pubmed/8698630
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.1996.tb00292.x
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados